GW&K Investment Management LLC raised its holdings in Exponent, Inc. (NASDAQ:EXPO) by 4.0% during the third quarter, Holdings Channel.com reports. The firm owned 933,876 shares of the business services provider’s stock after purchasing an additional 35,884 shares during the quarter. Exponent makes up 0.9% of GW&K Investment Management LLC’s investment portfolio, making the stock its 16th largest position. GW&K Investment Management LLC’s holdings in Exponent were worth $65,278,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. CWM LLC boosted its stake in shares of Exponent by 1,710.0% during the 3rd quarter. CWM LLC now owns 362 shares of the business services provider’s stock worth $25,000 after acquiring an additional 342 shares in the last quarter. Quest Capital Management Inc. ADV purchased a new stake in shares of Exponent during the 3rd quarter worth approximately $25,000. Tower Research Capital LLC TRC boosted its stake in shares of Exponent by 787.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 612 shares of the business services provider’s stock worth $36,000 after acquiring an additional 543 shares in the last quarter. Price Capital Management Inc. purchased a new stake in shares of Exponent during the 3rd quarter worth approximately $63,000. Finally, NN Investment Partners Holdings N.V. purchased a new stake in shares of Exponent during the 2nd quarter worth approximately $91,000. 88.00% of the stock is currently owned by institutional investors and hedge funds.
Shares of NASDAQ:EXPO traded up $0.04 during trading on Friday, hitting $62.99. 132,500 shares of the stock were exchanged, compared to its average volume of 230,642. The company has a market cap of $3.32 billion, a PE ratio of 50.39 and a beta of 0.37. The company has a current ratio of 3.48, a quick ratio of 3.60 and a debt-to-equity ratio of 0.05. The company has a fifty day moving average price of $67.45 and a two-hundred day moving average price of $63.71. Exponent, Inc. has a 12-month low of $46.00 and a 12-month high of $72.70.
Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, October 17th. The business services provider reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.02. The business had revenue of $101.50 million during the quarter, compared to the consensus estimate of $100.17 million. Exponent had a return on equity of 23.62% and a net margin of 19.88%. The business’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.32 EPS. Equities research analysts anticipate that Exponent, Inc. will post 1.5 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, December 5th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.02%. Exponent’s payout ratio is 51.20%.
In related news, CFO Richard L. Schlenker, Jr. sold 75,530 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $70.26, for a total transaction of $5,306,737.80. Following the completion of the sale, the chief financial officer now directly owns 251,805 shares of the company’s stock, valued at approximately $17,691,819.30. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Paul R. Johnston sold 7,000 shares of the company’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $63.76, for a total transaction of $446,320.00. Following the sale, the director now directly owns 95,507 shares of the company’s stock, valued at $6,089,526.32. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 128,765 shares of company stock valued at $8,873,648. Insiders own 2.30% of the company’s stock.
EXPO has been the topic of several research analyst reports. Cantor Fitzgerald boosted their price target on Exponent from $64.00 to $73.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Zacks Investment Research raised Exponent from a “hold” rating to a “strong-buy” rating and set a $81.00 price target on the stock in a research note on Monday, September 23rd. William Blair reissued a “market perform” rating on shares of Exponent in a research note on Friday, October 18th. ValuEngine lowered Exponent from a “hold” rating to a “sell” rating in a research note on Wednesday, October 2nd. Finally, BidaskClub lowered Exponent from a “hold” rating to a “sell” rating in a research note on Thursday, October 24th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $76.75.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Recommended Story: Street Name
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.